Scarica l'app Stockscreener
9.37
6.02%
-0.60
Dopo l'orario di chiusura:
9.30
-0.07
-0.75%
Personalis Inc Borsa (PSNL) Ultime notizie
Personalis, Inc. (PSNL) Stock Analysis: A 11.76% Potential Upside Amidst Revenue Challenges - DirectorsTalk Interviews
Wall Street Zen Upgrades Personalis (NASDAQ:PSNL) to Hold - MarketBeat
Is Personalis Inc.’s growth already priced inJuly 2025 Recap & Consistent Return Strategy Ideas - mfd.ru
Personalis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - BioSpace
Insider Selling: Personalis (NASDAQ:PSNL) CFO Sells $13,811.50 in Stock - Defense World
What 9 Analyst Ratings Have To Say About Personalis - Benzinga
Guggenheim Raises Price Target for Personalis (PSNL) to $13.00 | - GuruFocus
Gainers Report: Is Personalis Incs growth already priced inShare Buyback & Entry Point Strategy Guides - baoquankhu1.vn
Personalis (NASDAQ:PSNL) Sets New 12-Month High – Still a Buy? - Defense World
Hedge Fund Bets: Should you avoid Personalis Inc stock right nowEarnings Risk Summary & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Personalis, Inc. $PSNL Shares Purchased by AIGH Capital Management LLC - MarketBeat
Personalis (NASDAQ:PSNL) CFO Sells $13,811.50 in Stock - MarketBeat
Personalis CFO Tachibana sells $13,811 in shares By Investing.com - Investing.com Australia
Personalis CFO Tachibana sells $13,811 in shares - Investing.com
Personalis (NASDAQ:PSNL) Reaches New 12-Month HighWhat's Next? - MarketBeat
Personalis Sees Revised Reimbursement Rates for Cancer Tests - MSN
Personalis (NASDAQ:PSNL) Trading 14.8% HigherStill a Buy? - MarketBeat
Market Rankings: How does PLRX perform in inflationary periodsWeekly Stock Recap & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
How A New Price Target Is Shaping The Evolving Story For Personalis (PSNL) - Yahoo Finance
Winners Losers: Is Personalis Incs growth already priced inDollar Strength & Risk Controlled Daily Plans - baoquankhu1.vn
Personalis, Inc. (NASDAQ:PSNL) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Trading Action: Can Personalis Inc grow without external fundingJuly 2025 Volume & Weekly High Return Stock Forecasts - baoquankhu1.vn
Personalis, Inc. (NASDAQ:PSNL) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable - simplywall.st
Personalis (NASDAQ:PSNL) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Personalis, Inc. (PSNL) Stock Analysis: A Promising 14.46% Upside Potential Amid Strategic Collaboration - DirectorsTalk Interviews
Aug Closing: Is Personalis Inc a defensive stockMarket Volume Report & Technical Pattern Recognition Alerts - baoquankhu1.vn
Aug Technicals: Is Personalis Inc showing insider buyingRate Cut & Reliable Momentum Entry Alerts - baoquankhu1.vn
cathie wood’s ARK stock trades highlight intellia, personalis buys By Investing.com - Investing.com Nigeria
cathie wood’s ARK stock trades highlight intellia, personalis buys - Investing.com
Personalis Stock Pre-Market (-4.0%): Downgrade Cites Competitive Headwinds - Trefis
Stop Loss: Can Personalis Inc stock double in the next yearTreasury Yields & Verified Swing Trading Watchlists - baoquankhu1.vn
Can Personalis Inc stock double in the next yearTrade Analysis Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn
Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™ - FinancialContent
Risk Hedge: Is Personalis Inc benefiting from interest rate changesWeekly Market Outlook & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Personalis, Inc. Announces Early Access Launch of Real-Time Variant Tracker - marketscreener.com
Personalis Reports Q3 2025 Financial Results - MSN
Will Personalis Inc. (04X) stock split increase liquidityWeekly Loss Report & Free Accurate Trade Setup Notifications - ulpravda.ru
Personalis (NASDAQ:PSNL) Given “Buy” Rating at BTIG Research - Defense World
Personalis (PSNL) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
BTIG Reiterates Buy Rating for Personalis (PSNL) with $12 Target - GuruFocus
BTIG Research Reaffirms Buy Rating for Personalis (NASDAQ:PSNL) - MarketBeat
Is Personalis Inc. stock attractive for long term wealth building2025 Historical Comparison & Expert Curated Trade Setups - Улправда
Why Personalis Inc. stock remains a top recommendationJuly 2025 Market Mood & Risk Controlled Stock Alerts - Улправда
Is Personalis Inc. stock attractive for hedge fundsEarnings Recap Summary & Consistent Return Strategy Ideas - ulpravda.ru
Personalis (PSNL) Achieves Remarkable Growth in Clinical Volumes - GuruFocus
Can Personalis Inc. stock outperform in 2025 bull marketGap Down & Real-Time Buy Zone Alerts - ulpravda.ru
Is Personalis Inc. stock a buy for dividend growth2025 Macro Impact & Real-Time Chart Breakout Alerts - Улправда
Will Personalis Inc. stock remain a Wall Street favoriteQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - Улправда
The $537B Precision Pivot: Why Molecular Monitoring is the New Oncology Standard - The Globe and Mail
Personalis Reports Select Preliminary Fourth Quarter and Full Year 2025 Results and Recent Highlights - BioSpace
PSNL Achieves Key Medicare Coverage Milestone for Breast Cancer - GuruFocus
1.19%
0.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):